Overview

Naltrexone SR and Fluoxetine Combination Therapy in Subjects With Obsessive-Compulsive Disorder

Status:
Terminated
Trial end date:
2008-12-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine if the combination of naltrexone SR and fluoxetine is more effective in treating the symptoms of obsessive-compulsive disorder (OCD)than either fluoxetine alone or naltrexone SR alone.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Orexigen Therapeutics, Inc
Treatments:
Fluoxetine
Naltrexone
Criteria
Inclusion Criteria:

- Male or female subjects, 18 to 60 years of age (inclusive)

- Outpatients with a current diagnosis of OCD that have received previous therapy

- Negative serum pregnancy test as screening in women of child-bearing potential

- If a woman of child-bearing potential, must agreed to use an acceptable and effective
form of contraception

- No clinically significant abnormality on electrocardiogram (ECG)

- No clinically significant laboratory abnormality at screening

- Negative urine drug screen

- Must be considered reliable and possess a level of understanding that enables the
subject to provide written informed consent and to comply with protocol procedures and
schedule

Exclusion Criteria:

- Diagnosis of substance dependence

- Diagnosis of substance abuse (except for nicotine and caffeine)

- Serious or unstable medical illnesses

- Lifetime history of bipolar disorder, schizophrenia or other psychosis, bulimia,
anorexia nervosa, Pervasive Developmental Disorder (PDD), Asperger's Syndrome or the
presence of antisocial or borderline personality disorder

- Diagnosis of tic disorder or Tourette's Syndrome

- Subjects diagnosed with impulse control disorder

- Known sensitivity or allergic reaction to either naltrexone or fluoxetine

- Any condition which in the opinion of the investigator or Sponsor makes the subject
unsuitable for inclusion in the study

- Immediate family of investigators, study personnel or Sponsor representatives